rs794999

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_133625.6(SYN2):​c.1516A>G​(p.Thr506Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.744 in 1,552,224 control chromosomes in the GnomAD database, including 432,406 homozygotes. In-silico tool predicts a benign outcome for this variant. 11/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 37742 hom., cov: 29)
Exomes 𝑓: 0.75 ( 394664 hom. )

Consequence

SYN2
NM_133625.6 missense

Scores

2
12

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 1.70

Publications

34 publications found
Variant links:
Genes affected
SYN2 (HGNC:11495): (synapsin II) This gene is a member of the synapsin gene family. Synapsins encode neuronal phosphoproteins which associate with the cytoplasmic surface of synaptic vesicles. Family members are characterized by common protein domains, and they are implicated in synaptogenesis and the modulation of neurotransmitter release, suggesting a potential role in several neuropsychiatric diseases. This member of the synapsin family encodes a neuron-specific phosphoprotein that selectively binds to small synaptic vesicles in the presynaptic nerve terminal. Polymorphisms in this gene are associated with abnormal presynaptic function and related neuronal disorders, including autism, epilepsy, bipolar disorder and schizophrenia. Alternative splicing of this gene results in multiple transcript variants. The tissue inhibitor of metalloproteinase 4 gene is located within an intron of this gene and is transcribed in the opposite direction. [provided by RefSeq, Feb 2014]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=6.864383E-7).
BP6
Variant 3-12187515-A-G is Benign according to our data. Variant chr3-12187515-A-G is described in ClinVar as Benign. ClinVar VariationId is 1298153.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.769 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SYN2NM_133625.6 linkc.1516A>G p.Thr506Ala missense_variant Exon 12 of 13 ENST00000621198.5 NP_598328.1 Q92777-1Q86VA8B3KRB3
SYN2XM_006713312.5 linkc.1033A>G p.Thr345Ala missense_variant Exon 9 of 10 XP_006713375.1
SYN2XM_017007087.2 linkc.844A>G p.Thr282Ala missense_variant Exon 8 of 9 XP_016862576.1
SYN2XM_006713313.3 linkc.745A>G p.Thr249Ala missense_variant Exon 9 of 10 XP_006713376.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SYN2ENST00000621198.5 linkc.1516A>G p.Thr506Ala missense_variant Exon 12 of 13 1 NM_133625.6 ENSP00000480050.1 Q92777-1
SYN2ENST00000439861.5 linkn.1135A>G non_coding_transcript_exon_variant Exon 9 of 10 2
ENSG00000288952ENST00000690965.2 linkn.527+4853T>C intron_variant Intron 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.699
AC:
105864
AN:
151518
Hom.:
37709
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.547
Gnomad AMI
AF:
0.916
Gnomad AMR
AF:
0.766
Gnomad ASJ
AF:
0.729
Gnomad EAS
AF:
0.684
Gnomad SAS
AF:
0.790
Gnomad FIN
AF:
0.791
Gnomad MID
AF:
0.775
Gnomad NFE
AF:
0.749
Gnomad OTH
AF:
0.738
GnomAD2 exomes
AF:
0.762
AC:
118931
AN:
156012
AF XY:
0.764
show subpopulations
Gnomad AFR exome
AF:
0.542
Gnomad AMR exome
AF:
0.854
Gnomad ASJ exome
AF:
0.733
Gnomad EAS exome
AF:
0.688
Gnomad FIN exome
AF:
0.787
Gnomad NFE exome
AF:
0.749
Gnomad OTH exome
AF:
0.769
GnomAD4 exome
AF:
0.749
AC:
1049306
AN:
1400588
Hom.:
394664
Cov.:
88
AF XY:
0.750
AC XY:
518431
AN XY:
690830
show subpopulations
African (AFR)
AF:
0.538
AC:
17045
AN:
31664
American (AMR)
AF:
0.846
AC:
30275
AN:
35798
Ashkenazi Jewish (ASJ)
AF:
0.738
AC:
18621
AN:
25220
East Asian (EAS)
AF:
0.670
AC:
24020
AN:
35870
South Asian (SAS)
AF:
0.804
AC:
63806
AN:
79314
European-Finnish (FIN)
AF:
0.778
AC:
38456
AN:
49456
Middle Eastern (MID)
AF:
0.805
AC:
4589
AN:
5700
European-Non Finnish (NFE)
AF:
0.749
AC:
808938
AN:
1079444
Other (OTH)
AF:
0.749
AC:
43556
AN:
58122
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
17438
34876
52314
69752
87190
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
19920
39840
59760
79680
99600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.699
AC:
105947
AN:
151636
Hom.:
37742
Cov.:
29
AF XY:
0.703
AC XY:
52046
AN XY:
74080
show subpopulations
African (AFR)
AF:
0.547
AC:
22547
AN:
41198
American (AMR)
AF:
0.767
AC:
11709
AN:
15272
Ashkenazi Jewish (ASJ)
AF:
0.729
AC:
2529
AN:
3468
East Asian (EAS)
AF:
0.684
AC:
3482
AN:
5088
South Asian (SAS)
AF:
0.790
AC:
3803
AN:
4814
European-Finnish (FIN)
AF:
0.791
AC:
8345
AN:
10552
Middle Eastern (MID)
AF:
0.776
AC:
228
AN:
294
European-Non Finnish (NFE)
AF:
0.749
AC:
50909
AN:
67926
Other (OTH)
AF:
0.739
AC:
1560
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.516
Heterozygous variant carriers
0
1595
3191
4786
6382
7977
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
828
1656
2484
3312
4140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.721
Hom.:
31370
Bravo
AF:
0.690
TwinsUK
AF:
0.750
AC:
2782
ALSPAC
AF:
0.729
AC:
2810
ESP6500AA
AF:
0.586
AC:
2232
ESP6500EA
AF:
0.764
AC:
6069
ExAC
AF:
0.669
AC:
54979
Asia WGS
AF:
0.733
AC:
2549
AN:
3476

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Nov 21, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

SYN2-related disorder Benign:1
Feb 26, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.058
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.29
CADD
Benign
18
DANN
Benign
0.70
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.28
Eigen_PC
Benign
-0.14
FATHMM_MKL
Uncertain
0.76
D
LIST_S2
Benign
0.23
T
MetaRNN
Benign
6.9e-7
T
MetaSVM
Benign
-1.0
T
PhyloP100
1.7
PrimateAI
Uncertain
0.58
T
Sift4G
Benign
0.44
T
Polyphen
0.0020
B
Vest4
0.029
ClinPred
0.068
T
GERP RS
2.5
Varity_R
0.14
gMVP
0.12

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs794999; hg19: chr3-12229015; COSMIC: COSV101413855; COSMIC: COSV101413855; API